Get the Stockscreener App
25.39
7.84%
1.845
After Hours:
25.41
0.025
+0.10%
Staar Surgical Co stock is traded at $25.39, with a volume of 6.50M.
It is up +7.84% in the last 24 hours and down -4.39% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$23.54
Open:
$27.25
24h Volume:
6.50M
Relative Volume:
6.41
Market Cap:
$1.25B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-13.15
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-2.06%
1M Performance:
-4.39%
6M Performance:
+47.85%
1Y Performance:
-3.41%
1-Day Range:
$25.03
$27.53
1-Week Range:
$23.28
$27.53
52-Week Range:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
25.39 | 1.16B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
558.13 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
188.82 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.67 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.52 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.07 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Mergers and acquisitions - TradingView
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - Yahoo Finance
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against - Investing.com
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ - Stocktwits
Broadwood continues to oppose STAAR sale to Alcon despite price bump By Investing.com - Investing.com UK
Swiss eyecare giant Alcon lifts bid for rival Staar - Reuters
Alcon (NYSE: ALC) Faces Broadwood Pushback on Raised $30.75 STAAR Deal Offer - Stock Titan
Alcon Increases Offer to Acquire Staar to $1.6B - Orange County Business Journal
Academy Sports and Outdoors, Tronox, STAAR Surgical And Other Big Stocks Moving Higher On Tuesday - Benzinga
Alcon raises price target for STAAR Surgical stock to $30.75 in amended merger deal - Investing.com
Alcon, STAAR Amend Merger Agreement as Deal Looks Set to Move Forward - Medical Product Outsourcing
Alcon amends Staar merger agreement as deal looks set to move forward - MassDevice
Alcon raises offer to $30.75 per share in amended STAAR acquisition deal - Investing.com Australia
STAAR Surgical stock soars after Alcon raises acquisition offer By Investing.com - Investing.com India
Staar Surgical raises merger offer price in amended agreement with Alcon - Investing.com
Staar Surgical raises merger offer price in amended agreement with Alcon By Investing.com - Investing.com South Africa
Alcon (SIX/NYSE: ALC) ups STAAR acquisition bid to $30.75 per share, equity value $1.6B - Stock Titan
Egan-Jones reaffirms opposition to STAAR Surgical acquisition By Investing.com - Investing.com Australia
Why STAAR Surgical (STAA) Shares Are Plunging Today - Finviz
STAAR Surgical’s Sale To Alcon Faces Doubts And Pushback - Finimize
Broadwood urges STAAR shareholders to reject Alcon deal despite go-shop - Investing.com Canada
STAAR Surgical Announces Expiration of Go-Shop Period - TradingView
STAAR Surgical completes go-shop period with no competing bids By Investing.com - Investing.com India
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon - Yahoo Finance
Is STAAR Surgical Attractive After Multi Year Share Price Slide And DCF Upside? - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & SuppliesSpecialty Pack - Barchart.com
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms - AOL.com
STAAR Surgical: Is Broadwood Quietly Taking Over This Struggling Eye-Tech Stock? - Smartkarma
Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears - Investing.com
Broadwood Partners Pursues Meeting to Remove Three Staar Directors - Orange County Business Journal
Broadwood seeks to remove three STAAR Surgical directors amid sale dispute - Investing.com Nigeria
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors - Yahoo Finance
Midday Stock Roundup: Staar Surgical Falls After Go-Shop Period Expires - Orange County Business Journal
Staar Surgical (STAA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance UK
STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
Staar Surgical, Gold Royalty See Activist Action - MSN
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
Insider Buying: STAAR Surgical (NASDAQ:STAA) Major Shareholder Purchases 309,132 Shares of Stock - MarketBeat
Insider Stock Purchases: November 22, 2025 - Quiver Quantitative
STAAR Surgical Stock (STAA) Opinions on Alcon Merger Developments - Quiver Quantitative
Broadwood Partners buys STAAR Surgical (STAA) shares for $41 million By Investing.com - Investing.com Nigeria
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
Broadwood Partners buys STAAR Surgical (STAA) shares for $41 million - Investing.com
[DFAN14A] STAAR SURGICAL CO SEC Filing - Stock Titan
Can STAAR Surgical Company stock sustain revenue growth - newser.com
STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote - Investing.com Canada
How STAAR Surgical Company stock trades before earningsJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):